In part 5, the conclusion of this Exclusive Interview, Kathleen Wyne talks with Diabetes in Control Medical Editor Joy Pape during the AACE 2018 convention in Boston, MA about starting statins in adults with type 1.
Read More »Prediabetes in Adolescence Dramatically Increases Cardiovascular Risk
Getting diabetes in our later years increases risk for CVD, but getting diabetes or prediabetes as a youth increases risk for CVD and death dramatically.
Read More »What Comes First, Diabetes or Cancer?
New study shows that within the first two years of a diagnosis of cancer, the risk for type 2 diabetes increases.
Read More »Omnipod Insulin Delivery System Receives FDA Clearance
The Omnipod Dash™ device approved for commercialization and release in the U.S. by mid-2018.
Read More »Dual-Hormone Closed-Loop Delivery System Compatible with Exercise
Addition of glucagon prevents exercise-induced hypoglycemia.
Read More »Is There a Future for BGM?
Guest Post by David Kliff, Editor, Diabetic Investor
With each passing day, it’s becoming more apparent that CGM will replace BGM as the standard for glucose measurement. CGM systems are becoming more patient-friendly, i.e. no calibrations, simple insertion, and cheaper too. The data provided by CGM is transformative, leading to improved outcomes. It is no longer a question of if this will happen but when this will happen.
CGM for Type 2
Would you be open to using a CGM for your type 2 patients who are not on insulin? Follow the link to share your response.
Read More »Do These Raise Alzheimer’s Disease Risk?
Which one of the following is NOT associated with increased Alzheimer's disease risk?
A. Diabetes mellitusB. Statin use
C. High hemoglobin levels
D. Lower social engagement
Follow the link for the answer. Read More »
Aaron Vinik 2018 Transcript
In this Exclusive Interview transcript, Aaron Vinik discusses the role of the brain in diabetes, moving away from a glucose-centric view of diabetes, and the importance of looking at heart rate.
Read More »Aaron Vinik 2018 Complete Interview
AARON I. VINIK, MD, PhD, FCP, MACP, FACE is a global leader in basic and clinical neuropathy. He, in essence, has defined the heterogeneity of neuropathy, established a need for a modular approach depending on the particular nerve fiber damaged, and pioneered immunotherapy for autoimmune neuropathies. He was awarded a lifetime achievement award by EASD Neurodiab in 2011 for his contributions to the understanding of neuropathies. In 2016, he received the American College of Endocrinology (AACE) Distinction in Endocrinology Award in recognition of advancing the understanding of endocrinology through research and education.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.